ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.
Saved in:
| Title: | ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. |
|---|---|
| Authors: | Stecklein SR; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Kimler BF; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA., Yoder R; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Schwensen K; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Staley JM; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Khan QJ; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., O'Dea AP; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Nye LE; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Elia M; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Heldstab J; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Home T; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Hyter S; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Isakova K; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Pathak HB; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Sharma P; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu.; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2023 Mar 06; Vol. 9 (1), pp. 10. Date of Electronic Publication: 2023 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36878909 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stecklein+SR%22">Stecklein SR</searchLink>; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Kimler+BF%22">Kimler BF</searchLink>; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Yoder+R%22">Yoder R</searchLink>; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Schwensen+K%22">Schwensen K</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Staley+JM%22">Staley JM</searchLink>; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Khan+QJ%22">Khan QJ</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22O'Dea+AP%22">O'Dea AP</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Nye+LE%22">Nye LE</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Elia+M%22">Elia M</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Heldstab+J%22">Heldstab J</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Home+T%22">Home T</searchLink>; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Hyter+S%22">Hyter S</searchLink>; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Isakova+K%22">Isakova K</searchLink>; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Pathak+HB%22">Pathak HB</searchLink>; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Godwin+AK%22">Godwin AK</searchLink>; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Sharma+P%22">Sharma P</searchLink>; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu.; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2023 Mar 06; Vol. 9 (1), pp. 10. <i>Date of Electronic Publication: </i>2023 Mar 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36878909 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41523-023-00512-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 10 Titles: – TitleFull: ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stecklein SR – PersonEntity: Name: NameFull: Kimler BF – PersonEntity: Name: NameFull: Yoder R – PersonEntity: Name: NameFull: Schwensen K – PersonEntity: Name: NameFull: Staley JM – PersonEntity: Name: NameFull: Khan QJ – PersonEntity: Name: NameFull: O'Dea AP – PersonEntity: Name: NameFull: Nye LE – PersonEntity: Name: NameFull: Elia M – PersonEntity: Name: NameFull: Heldstab J – PersonEntity: Name: NameFull: Home T – PersonEntity: Name: NameFull: Hyter S – PersonEntity: Name: NameFull: Isakova K – PersonEntity: Name: NameFull: Pathak HB – PersonEntity: Name: NameFull: Godwin AK – PersonEntity: Name: NameFull: Sharma P IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 03 Text: 2023 Mar 06 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2374-4677 Numbering: – Type: volume Value: 9 – Type: issue Value: 1 Titles: – TitleFull: NPJ breast cancer Type: main |
| ResultId | 1 |